🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Radiolabeled monoclonal antibodies can locate cancer cells and d...
Status
Completed
Location
Garden State Cancer Center
Start Date
1998-04
Trial ID
NCT00004084
Treatments Being Tested
RATIONALE: Radiolabeled monoclonal antibodies can locate cancer cells and e...
Status
Unknown
Location
Garden State Cancer Center
Start Date
1997-06
Trial ID
NCT00004086
This will be an open label, multiple center, non-randomized, dose-escalatio...
Status
Completed
Location
Research Unit 463 INSERM
Start Date
2002-08
Trial ID
NCT00421395
Treatments Being Tested
The purpose of this trial is to determine the safety of a 90Y-radiolabeled,...
Status
Completed
Location
Multiple Locations
Start Date
2000-08
Trial ID
NCT00061425
Treatments Being Tested
RATIONALE: Diagnostic imaging procedures using radiolabeled monoclonal anti...
Status
Unknown
Location
Cedars-Sinai Medical Center
Start Date
1997-03
Trial ID
NCT00003337
Treatments Being Tested
The purpose of this trial is to determine the safety of 90Y-hLL2 at differe...
Status
Terminated
Location
Fox Chase Cancer Center
Start Date
2003-03
Trial ID
NCT00054834
Treatments Being Tested
The purpose of this study is to determine whether fractionated RIT with Epr...
Status
Unknown
Location
CHU Nantes
Start Date
2010-11
Trial ID
NCT01354457
Treatments Being Tested
RATIONALE: Radiolabeled monoclonal antibodies can locate cancer cells and d...
Status
Completed
Location
Garden State Cancer Center
Start Date
1998-02
Trial ID
NCT00004107